2nd Quarter - Report

CROWELL & MORING LLP for NATIONAL ASSOCIATION OF NUCLEAR PHARMACIES

Firm
Client
Income
$5,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement.

LobbyistCovered position, as disclosed
MICHAEL GILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

LobbyistCovered position, as disclosed
MICHAEL GILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 959 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.